NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway
: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of via the Notch signaling pathway by sponging miR-34a-5p. : We appl...
Saved in:
| Published in | Frontiers in molecular neuroscience Vol. 11; p. 225 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Research Foundation
18.07.2018
Frontiers Media S.A |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | : The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of
via the Notch signaling pathway by sponging miR-34a-5p.
: We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and
and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between
and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression
.
: Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted
. Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated
that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and
.
: CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate
and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression. |
|---|---|
| AbstractList | Objective: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of NOTCH1 via the Notch signaling pathway by sponging miR-34a-5p. Methods: We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and NOTCH and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between NOTCH1 and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression in vivo. Results: Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted NOTCH1. Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated in vivo that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and NOTCH1. Conclusion: CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate NOTCH1 and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression.Objective: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of NOTCH1 via the Notch signaling pathway by sponging miR-34a-5p. Methods: We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and NOTCH and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between NOTCH1 and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression in vivo. Results: Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted NOTCH1. Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated in vivo that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and NOTCH1. Conclusion: CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate NOTCH1 and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression. : The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of via the Notch signaling pathway by sponging miR-34a-5p. : We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression . : Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted . Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and . : CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression. Objective: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of NOTCH1 via the Notch signaling pathway by sponging miR-34a-5p. Methods: We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between 3 glioma tissue samples and 3 paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and NOTCH and identify their correlation in glioma. RIP validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between NOTCH1 and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression in vivo. Results: Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted NOTCH1. Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated in vivo that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and NOTCH1. Conclusion: CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate NOTCH1 and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer Objective : The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of NOTCH1 via the Notch signaling pathway by sponging miR-34a-5p. Methods : We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and NOTCH and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between NOTCH1 and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression in vivo . Results : Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted NOTCH1 . Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated in vivo that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and NOTCH1 . Conclusion : CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate NOTCH1 and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression. Objective: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the influence that circNFIX has on glioma progression through the upregulation of NOTCH1 via the Notch signaling pathway by sponging miR-34a-5p.Methods: We applied five methods, CIRCexplorer2, circRNA-finder, CIRI, find-circ and MapSplice2, to screen for circRNAs with differential expression between three glioma tissue samples and three paired normal tissue samples. The GSEA software was used to confirm whether significantly different pathways were activated or inactivated in glioma tissues. The binding sites between circNFIX and miR-34a-5p were confirmed by TargetScan. QRT-PCR and western blot were used to measure the relative expression levels of circNFIX, miR-34a-5p and NOTCH and identify their correlation in glioma. RNA immunoprecipitation (RIP) validated the binding relationship between circNFIX and miR-34a-5p, while the targeted relationship between NOTCH1 and miR-34a-5p was verified by a dual luciferase reporter assay. Cell viability and mobility were examined by a CCK-8 assay and wound healing assay, and a flow cytometry assay was employed to analyze cell apoptosis. The nude mouse transplantation tumor experiment verified that si-circNFIX exerted a suppressive effect on glioma progression in vivo.Results: Twelve circRNAs were differentially expressed between the tissue types. Of those, circNFIX was the sole circRNA to be overexpressed in glioma among the five methods of finding circRNAs. In addition, the Notch signaling pathway was considerably upregulated in tumor tissues compared with the paired normal brain tissues. It was determined that circNFIX acted as a sponge of miR-34a-5p, a miRNA that targeted NOTCH1. Downregulation of circNFIX and upregulation of miR-34a-5p both inhibited cell propagation and migration. Furthermore, a miR-34a-5p inhibitor neutralized the suppressive effect of si-circNFIX on glioma cells. Si-circNFIX and miR-34a-5p mimics promoted cell apoptosis. Moreover, it was demonstrated in vivo that si-circNFIX could suppress glioma growth by regulating miR-34a-5p and NOTCH1.Conclusion: CircNFIX was markedly upregulated in glioma cells. CircNFIX could regulate NOTCH1 and the Notch signaling pathway to promote glioma progression by sponging miR-34a-5p via the Notch signaling pathway. This finding provided a deeper insight into the function of circNFIX in human glioma cancer progression. |
| Author | Jiang, Hong Yu, Hongquan Qi, Ling Xu, Haiyang Zhang, Yu Ding, Lijuan |
| AuthorAffiliation | 1 Department of Oncological Neurosurgery, The First Hospital of Jilin University , Changchun , China 4 Department of Radio-oncology, The First Hospital of Jilin University , Changchun , China 2 Department of Neurosurgery, The First Hospital of Jilin University , Changchun , China 3 Department of Pathophysiology, Jilin Medical University , Jilin , China 5 Department of Ophthalmology, China-Japan Union Hospital of Jilin University , Changchun , China |
| AuthorAffiliation_xml | – name: 2 Department of Neurosurgery, The First Hospital of Jilin University , Changchun , China – name: 5 Department of Ophthalmology, China-Japan Union Hospital of Jilin University , Changchun , China – name: 1 Department of Oncological Neurosurgery, The First Hospital of Jilin University , Changchun , China – name: 3 Department of Pathophysiology, Jilin Medical University , Jilin , China – name: 4 Department of Radio-oncology, The First Hospital of Jilin University , Changchun , China |
| Author_xml | – sequence: 1 givenname: Haiyang surname: Xu fullname: Xu, Haiyang – sequence: 2 givenname: Yu surname: Zhang fullname: Zhang, Yu – sequence: 3 givenname: Ling surname: Qi fullname: Qi, Ling – sequence: 4 givenname: Lijuan surname: Ding fullname: Ding, Lijuan – sequence: 5 givenname: Hong surname: Jiang fullname: Jiang, Hong – sequence: 6 givenname: Hongquan surname: Yu fullname: Yu, Hongquan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30072869$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kttr2zAUh83oWC_b-56GYS97cXYkWbL0Miih7QIlK9kGexOyLo6CbWWS05H_fnbSjrawJ13Odz4O0u88O-lDb7PsPYIZIVx8dn0X2hkGxGcAGNNX2RliDBcUhDh5sj_NzlPaADDMKHmTnRKACnMmzrJ6eb34lc991LtWxXy1vMzvYujCYFN-0_rQqencRJuSD31e7_OVbUZ08H2Td35VkFIVdJvfe5Uvw6DX-Xff9KqdyndqWP9R-7fZa6faZN89rBfZz-urH_Ovxe23m8X88rbQpYChKK0wnDlWGqpqaisrBEMYcVEjRxFnVIC1zjKNcWlwpcFUFBxVBiOnDdbkIlscvSaojdxG36m4l0F5ebgIsZEqDl63VhqNjVCa1KxyJVWuLi2qOcKidtwSmFxfjq7tru6s0bYfomqfSZ9Xer-WTbiXDCgHwUbBpwdBDL93Ng2y80nbtlW9DbskMXBSIQwYRvTjC3QTdnF8w5EiIChAKcqR-vB0on-jPH7lCLAjoGNIKVontR_GfwrTgL6VCOSUGXnIjJwyIw-ZGRvhReOj-78tfwHvvMTh |
| CitedBy_id | crossref_primary_10_1016_j_isci_2023_107564 crossref_primary_10_1007_s12032_024_02513_3 crossref_primary_10_1155_2019_5938035 crossref_primary_10_3389_fmolb_2020_577938 crossref_primary_10_3892_ol_2019_10854 crossref_primary_10_1016_j_brainres_2024_148990 crossref_primary_10_3389_fcell_2021_617281 crossref_primary_10_1016_j_prp_2019_152620 crossref_primary_10_1158_1055_9965_EPI_20_0796 crossref_primary_10_3389_fonc_2021_705059 crossref_primary_10_1002_jcb_28820 crossref_primary_10_1016_j_ymeth_2022_07_011 crossref_primary_10_1186_s12943_019_1121_0 crossref_primary_10_18632_aging_203368 crossref_primary_10_3389_fcell_2021_754880 crossref_primary_10_3390_ijms21197001 crossref_primary_10_1002_1878_0261_12830 crossref_primary_10_2147_OTT_S272616 crossref_primary_10_3390_ijms23052811 crossref_primary_10_1186_s12943_019_1002_6 crossref_primary_10_2174_0118715273277458231213063147 crossref_primary_10_1007_s13273_024_00475_1 crossref_primary_10_1016_j_jbc_2024_107987 crossref_primary_10_3390_s23031482 crossref_primary_10_1097_FJC_0000000000001095 crossref_primary_10_1016_j_heliyon_2024_e37089 crossref_primary_10_1016_j_ijbiomac_2022_09_203 crossref_primary_10_17816_RCF204335_384 crossref_primary_10_3389_fcell_2021_792185 crossref_primary_10_3389_fphys_2019_00432 crossref_primary_10_1016_j_humgen_2023_201156 crossref_primary_10_1038_s42003_022_03011_w crossref_primary_10_1089_cbr_2020_3575 crossref_primary_10_2147_CMAR_S272309 crossref_primary_10_3390_pharmaceutics15051439 crossref_primary_10_1016_j_lfs_2022_120975 crossref_primary_10_1016_j_csbj_2021_01_018 crossref_primary_10_3389_fgene_2021_675498 crossref_primary_10_3390_ijms241612579 crossref_primary_10_1002_jcb_28313 crossref_primary_10_3389_fcell_2023_1116805 crossref_primary_10_3390_cancers13112744 crossref_primary_10_1016_j_cca_2024_120003 crossref_primary_10_3390_biomedicines10082031 crossref_primary_10_3390_ijms24054293 crossref_primary_10_3390_cells11142130 crossref_primary_10_3892_etm_2024_12662 crossref_primary_10_3389_fsurg_2022_983958 crossref_primary_10_1186_s13046_019_1483_6 crossref_primary_10_1002_mco2_699 crossref_primary_10_3390_ncrna5020036 crossref_primary_10_1038_s41392_020_0194_y crossref_primary_10_1007_s13577_022_00835_w crossref_primary_10_1038_s41598_024_63827_w crossref_primary_10_1021_acs_molpharmaceut_3c00933 crossref_primary_10_3390_ijms20040861 crossref_primary_10_3389_fendo_2020_555243 crossref_primary_10_1111_cns_14500 crossref_primary_10_1186_s12935_021_01767_5 crossref_primary_10_1016_j_canlet_2023_216189 crossref_primary_10_2147_OTT_S243833 crossref_primary_10_1007_s00432_022_04011_3 crossref_primary_10_1002_mgg3_673 crossref_primary_10_1186_s11658_022_00354_4 crossref_primary_10_3390_bios11070237 crossref_primary_10_1016_j_bcp_2022_115038 crossref_primary_10_1016_j_intimp_2023_110879 crossref_primary_10_3389_fimmu_2023_1039084 crossref_primary_10_1016_j_amjms_2020_08_008 crossref_primary_10_1016_j_semcdb_2021_04_002 crossref_primary_10_3390_cells10092476 crossref_primary_10_3390_ijms232314665 crossref_primary_10_1007_s12032_023_02275_4 crossref_primary_10_1016_j_semcancer_2020_12_026 crossref_primary_10_1016_j_cbi_2022_109919 crossref_primary_10_1038_s41598_020_73951_y crossref_primary_10_1002_kjm2_12632 crossref_primary_10_1007_s12031_018_1211_2 crossref_primary_10_3892_ijo_2020_5049 crossref_primary_10_1007_s10528_022_10228_1 crossref_primary_10_2174_0115680266300535240514104107 crossref_primary_10_3762_bjnano_11_26 crossref_primary_10_1007_s12035_019_1627_x crossref_primary_10_1016_j_biopha_2020_110251 crossref_primary_10_1016_j_canlet_2020_03_002 crossref_primary_10_3390_cancers13071555 crossref_primary_10_1016_j_gene_2025_149214 crossref_primary_10_1186_s12915_024_01826_z crossref_primary_10_1016_j_mce_2020_111140 crossref_primary_10_1093_clinchem_hvab254 crossref_primary_10_1097_MD_0000000000019171 crossref_primary_10_1007_s11626_020_00476_z crossref_primary_10_1016_j_mam_2021_101039 |
| Cites_doi | 10.1002/(sici)1097-4652(199912)181:3<393::aid-jcp3>3.0.co;2-6 10.1093/nar/gkx315 10.1111/j.1601-0825.2006.01334.x 10.1371/journal.pone.0182305 10.1182/blood.v99.9.3398 10.18632/oncotarget.18671 10.1080/09168451.2017.1364965 10.1016/j.bbrc.2013.12.136 10.18632/oncotarget.11523 10.1002/dvdy.10278 10.1111/cas.13401 10.1371/journal.pgen.1003777 10.1016/j.bbrc.2018.01.076 10.1073/pnas.0907781106 10.1136/jmedgenet-2016-103758 10.1038/cr.2015.82 10.1016/j.molcel.2017.02.017 10.1371/journal.pone.0033844 10.2147/ndt.s137171 10.3892/ol.2017.5870 10.1371/journal.pone.0006816 10.1093/bib/bbw053 10.1016/j.critrevonc.2017.10.003 10.1177/1010428317705850 10.1007/s11060-013-1119-1 10.7150/ijms.19565 10.1038/cr.2017.136 10.18632/oncotarget.16442 10.4161/cc.9.6.10987 10.1016/j.biopha.2016.12.100 10.1186/1471-2407-8-266 10.1038/srep22572 10.18632/oncotarget.14807 10.3892/ol.2015.3179 10.1186/s13059-015-0801-3 10.1038/nature04940 10.1111/cas.12656 10.1016/j.molcel.2017.02.021 10.1093/bioinformatics/btp120 10.1016/j.canlet.2009.11.012 10.3892/or.2017.5712 10.1371/journal.pone.0030590 10.1016/j.cell.2016.03.020 10.1155/2014/381917 10.1002/hep.29270 10.1038/nmeth.1226 |
| ContentType | Journal Article |
| Copyright | 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2018 Xu, Zhang, Qi, Ding, Jiang and Yu. 2018 Xu, Zhang, Qi, Ding, Jiang and Yu |
| Copyright_xml | – notice: 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2018 Xu, Zhang, Qi, Ding, Jiang and Yu. 2018 Xu, Zhang, Qi, Ding, Jiang and Yu |
| DBID | AAYXX CITATION NPM 3V. 7TK 7XB 88I 8FE 8FH 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.3389/fnmol.2018.00225 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One ProQuest Central Korea ProQuest Central Student SciTech Premium Collection Biological Sciences ProQuest Science Database (NC LIVE) ProQuest Biological Science Database (NC LIVE) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1662-5099 |
| ExternalDocumentID | oai_doaj_org_article_dc2d9ac3b67f45afb4e1b8129bf8e30c PMC6058096 30072869 10_3389_fnmol_2018_00225 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 29H 2WC 53G 5GY 5VS 88I 8FE 8FH 9T4 AAFWJ AAYXX ABUWG ACGFO ACGFS ACPRK ACXDI ADBBV ADRAZ AEGXH AENEX AFKRA AFPKN AIAGR ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION CS3 DIK DWQXO E3Z EMOBN F5P GNUQQ GROUPED_DOAJ GX1 HCIFZ HYE KQ8 LK8 M2P M48 M7P M~E O5R O5S OK1 OVT PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TR2 C1A IAO IEA IHR IPNFZ NPM RIG 3V. 7TK 7XB 8FK PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c490t-4e9d86f64d5ab5e7e99612189b1f5186590eefe6c224d27c0d750f5ad21fcd2c3 |
| IEDL.DBID | M48 |
| ISSN | 1662-5099 |
| IngestDate | Wed Aug 27 01:02:17 EDT 2025 Thu Aug 21 18:07:57 EDT 2025 Fri Jul 11 16:14:25 EDT 2025 Fri Jul 25 11:47:12 EDT 2025 Wed Feb 19 02:42:15 EST 2025 Tue Jul 01 01:45:52 EDT 2025 Thu Apr 24 23:04:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Notch signaling pathway glioma NOTCH1 NFIX circular RNA miR-34a-5p |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c490t-4e9d86f64d5ab5e7e99612189b1f5186590eefe6c224d27c0d750f5ad21fcd2c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Reviewed by: Davide De Pietri Tonelli, Fondazione Istituto Italiano di Technologia, Italy; Cristiana Tanase, Victor Babes National Institute of Pathology, Romania Edited by: Andrei Surguchov, University of Kansas Medical Center, United States |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnmol.2018.00225 |
| PMID | 30072869 |
| PQID | 2309500494 |
| PQPubID | 2046457 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_dc2d9ac3b67f45afb4e1b8129bf8e30c pubmedcentral_primary_oai_pubmedcentral_nih_gov_6058096 proquest_miscellaneous_2083712020 proquest_journals_2309500494 pubmed_primary_30072869 crossref_citationtrail_10_3389_fnmol_2018_00225 crossref_primary_10_3389_fnmol_2018_00225 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-07-18 |
| PublicationDateYYYYMMDD | 2018-07-18 |
| PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-18 day: 18 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Lausanne |
| PublicationTitle | Frontiers in molecular neuroscience |
| PublicationTitleAlternate | Front Mol Neurosci |
| PublicationYear | 2018 |
| Publisher | Frontiers Research Foundation Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Research Foundation – name: Frontiers Media S.A |
| References | Ji (B14) 2009; 4 Yao (B43) 2007; 13 Zhang (B45) 2017; 8 Chen (B5) 2016; 53 Pamudurti (B28) 2017; 66 Trapnell (B33) 2009; 25 Fang (B8) 2017; 39 Ahir (B1) 2017; 120 Silber (B31) 2012; 7 Wang (B37) 2010; 292 Bezerra (B3) 2014; 2014 Li (B19) 2018; 498 Ji (B13) 2008; 8 Wang (B35) 2017; 13 Han (B12) 2017; 66 Jundt (B16) 2002; 99 Guarnerio (B10) 2016; 165 Guessous (B11) 2010; 9 Mortazavi (B100) 2008; 5 Rodriguez (B29) 2005; 294 Chen (B6) 2015; 10 Legnini (B18) 2017; 66 Yang (B42) 2016; 7 Lu (B25) 2017; 13 Militello (B27) 2017; 18 Xu (B40) 2017; 87 Wu (B39) 2003; 226 Xu (B41) 2017; 38 Subramaniam (B32) 2012; 7 Venø (B34) 2015; 16 Miele (B26) 1999; 181 Wang (B36) 2017; 8 Zhang (B46) 2017; 12 Li (B20) 2014; 444 Li (B22) 2015; 25 Zhang (B44) 2017; 8 Liang (B23) 2017; 7 Gao (B9) 2013; 113 Zhou (B47) 2017; 14 Androutsellis-Theotokis (B2) 2006; 442 Salzman (B30) 2013; 9 Kang (B17) 2015; 106 Li (B21) 2017; 45 Chi (B7) 2017; 108 Liu (B24) 2016; 6 Jin (B15) 2017; 81 Bezzi (B4) 2017; 27 Westhoff (B38) 2009; 106 28859546 - Biosci Biotechnol Biochem. 2017 Oct;81(10):1899-1907 20022691 - Cancer Lett. 2010 Jun 28;292(2):141-8 26171025 - Oncol Lett. 2015 Jul;10(1):329-336 15576902 - Methods Mol Biol. 2005;294:23-9 28639908 - Tumour Biol. 2017 Jun;39(6):1010428317705850 11964309 - Blood. 2002 May 1;99(9):3398-403 28627653 - Oncol Rep. 2017 Aug;38(2):725-734 28771526 - PLoS One. 2017 Aug 3;12(8):e0182305 26541409 - Genome Biol. 2015 Nov 05;16:245 28921827 - Cancer Sci. 2017 Dec;108(12):2366-2372 29337055 - Biochem Biophys Res Commun. 2018 Mar 25;498(1):254-261 28415618 - Oncotarget. 2017 May 23;8(21):34961-34970 25783790 - Cancer Sci. 2015 Jun;106(6):700-8 28924364 - Int J Med Sci. 2017 Aug 8;14(10):937-942 24039610 - PLoS Genet. 2013;9(9):e1003777 29198335 - Crit Rev Oncol Hematol. 2017 Dec;120:22-33 27613831 - Oncotarget. 2016 Sep 27;7(39):63449-63455 20007775 - Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8 26138677 - Cell Res. 2015 Aug;25(8):981-4 17944672 - Oral Dis. 2007 Nov;13(6):555-63 28129650 - Oncotarget. 2017 Feb 21;8(8):13264-13276 10528225 - J Cell Physiol. 1999 Dec;181(3):393-409 19289445 - Bioinformatics. 2009 May 1;25(9):1105-11 24393844 - Biochem Biophys Res Commun. 2014 Jan 31;444(1):6-12 26931159 - Sci Rep. 2016 Mar 02;6:22572 29086764 - Cell Res. 2017 Dec;27(12):1401-1402 22363450 - PLoS One. 2012;7(2):e30590 20190569 - Cell Cycle. 2010 Mar 15;9(6):1031-6 26945092 - J Med Genet. 2016 Jun;53(6):359-65 23529798 - J Neurooncol. 2013 Jun;113(2):221-8 18516045 - Nat Methods. 2008 Jul;5(7):621-8 28744405 - Am J Cancer Res. 2017 Jul 01;7(7):1566-1576 25050346 - Biomed Res Int. 2014;2014:381917 12666205 - Dev Dyn. 2003 Apr;226(4):675-89 28977896 - Oncotarget. 2017 Jun 27;8(37):61687-61697 27040497 - Cell. 2016 Apr 7;165(2):289-302 28068630 - Biomed Pharmacother. 2017 Mar;87:405-411 16799564 - Nature. 2006 Aug 17;442(7104):823-6 28344080 - Mol Cell. 2017 Apr 6;66(1):9-21.e7 28536644 - Oncol Lett. 2017 May;13(5):3866-3872 22479456 - PLoS One. 2012;7(3):e33844 19714243 - PLoS One. 2009 Aug 28;4(8):e6816 28520103 - Hepatology. 2017 Oct;66(4):1151-1164 28744130 - Neuropsychiatr Dis Treat. 2017 Jul 11;13:1805-1813 28472320 - Nucleic Acids Res. 2017 Jul 27;45(13):e120 28344082 - Mol Cell. 2017 Apr 6;66(1):22-37.e9 18803879 - BMC Cancer. 2008 Sep 21;8:266 27373735 - Brief Bioinform. 2017 Sep 1;18(5):780-788 |
| References_xml | – volume: 181 start-page: 393 year: 1999 ident: B26 article-title: Arbiter of differentiation and death: notch signaling meets apoptosis publication-title: J. Cell. Physiol. doi: 10.1002/(sici)1097-4652(199912)181:3<393::aid-jcp3>3.0.co;2-6 – volume: 45 start-page: e120 year: 2017 ident: B21 article-title: ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx315 – volume: 13 start-page: 555 year: 2007 ident: B43 article-title: γ-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells publication-title: Oral. Dis. doi: 10.1111/j.1601-0825.2006.01334.x – volume: 12 start-page: e0182305 year: 2017 ident: B46 article-title: An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation publication-title: PLoS One doi: 10.1371/journal.pone.0182305 – volume: 99 start-page: 3398 year: 2002 ident: B16 article-title: Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma publication-title: Blood doi: 10.1182/blood.v99.9.3398 – volume: 8 start-page: 61687 year: 2017 ident: B44 article-title: Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression publication-title: Oncotarget doi: 10.18632/oncotarget.18671 – volume: 81 start-page: 1899 year: 2017 ident: B15 article-title: MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway publication-title: Biosci. Biotechnol. Biochem. doi: 10.1080/09168451.2017.1364965 – volume: 444 start-page: 6 year: 2014 ident: B20 article-title: MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.12.136 – volume: 7 start-page: 63449 year: 2016 ident: B42 article-title: Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway publication-title: Oncotarget doi: 10.18632/oncotarget.11523 – volume: 226 start-page: 675 year: 2003 ident: B39 article-title: Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors publication-title: Dev. Dyn. doi: 10.1002/dvdy.10278 – volume: 108 start-page: 2366 year: 2017 ident: B7 article-title: miR-203 inhibits cell proliferation, invasion and migration of non-small-cell lung cancer by downregulating RGS17 publication-title: Cancer Sci. doi: 10.1111/cas.13401 – volume: 9 start-page: e1003777 year: 2013 ident: B30 article-title: Cell-type specific features of circular RNA expression publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1003777 – volume: 498 start-page: 254 year: 2018 ident: B19 article-title: A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of miR-142–3p target ITGB8 in glioma publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.01.076 – volume: 106 start-page: 22293 year: 2009 ident: B38 article-title: Alterations of the Notch pathway in lung cancer publication-title: Proc. Natl. Acad. Sci. U S A doi: 10.1073/pnas.0907781106 – volume: 53 start-page: 359 year: 2016 ident: B5 article-title: Circular RNAs: a new frontier in the study of human diseases publication-title: J. Med. Genet. doi: 10.1136/jmedgenet-2016-103758 – volume: 25 start-page: 981 year: 2015 ident: B22 article-title: Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis publication-title: Cell Res. doi: 10.1038/cr.2015.82 – volume: 294 start-page: 23 year: 2005 ident: B29 article-title: Wound-healing assay publication-title: Methods Mol. Biol. – volume: 66 start-page: 22.e9 year: 2017 ident: B18 article-title: Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis publication-title: Mol. Cell doi: 10.1016/j.molcel.2017.02.017 – volume: 7 start-page: e33844 year: 2012 ident: B31 article-title: miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis publication-title: PLoS One doi: 10.1371/journal.pone.0033844 – volume: 13 start-page: 1805 year: 2017 ident: B35 article-title: Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway publication-title: Neuropsychiatr. Dis. Treat. doi: 10.2147/ndt.s137171 – volume: 13 start-page: 3866 year: 2017 ident: B25 article-title: MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb publication-title: Oncol. Lett. doi: 10.3892/ol.2017.5870 – volume: 4 start-page: e6816 year: 2009 ident: B14 article-title: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells publication-title: PLoS One doi: 10.1371/journal.pone.0006816 – volume: 18 start-page: 780 year: 2017 ident: B27 article-title: Screening and validation of lncRNAs and circRNAs as miRNA sponges publication-title: Brief Bioinform. doi: 10.1093/bib/bbw053 – volume: 120 start-page: 22 year: 2017 ident: B1 article-title: MicroRNAs in glioblastoma pathogenesis and therapy: a comprehensive review publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2017.10.003 – volume: 39 start-page: 1010428317705850 year: 2017 ident: B8 article-title: Circular RNAs play an important role in late-stage gastric cancer: circular RNA expression profiles and bioinformatics analyses publication-title: Tumour Biol. doi: 10.1177/1010428317705850 – volume: 113 start-page: 221 year: 2013 ident: B9 article-title: Expression level of human miR-34a correlates with glioma grade and prognosis publication-title: J. Neurooncol. doi: 10.1007/s11060-013-1119-1 – volume: 14 start-page: 937 year: 2017 ident: B47 article-title: miR-224 controls human colorectal cancer cell line HCT116 proliferation by targeting Smad4 publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.19565 – volume: 27 start-page: 1401 year: 2017 ident: B4 article-title: A circular twist on microRNA regulation publication-title: Cell Res. doi: 10.1038/cr.2017.136 – volume: 8 start-page: 34961 year: 2017 ident: B45 article-title: Circular RNA alterations are involved in resistance to avian leukosis virus subgroup-J-induced tumor formation in chickens publication-title: Oncotarget doi: 10.18632/oncotarget.16442 – volume: 9 start-page: 1031 year: 2010 ident: B11 article-title: microRNA-34a is tumor suppressive in brain tumors and glioma stem cells publication-title: Cell Cycle doi: 10.4161/cc.9.6.10987 – volume: 87 start-page: 405 year: 2017 ident: B40 article-title: Potential mechanisms of microRNA-129–5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2016.12.100 – volume: 8 start-page: 266 year: 2008 ident: B13 article-title: Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres publication-title: BMC Cancer doi: 10.1186/1471-2407-8-266 – volume: 7 start-page: 1566 year: 2017 ident: B23 article-title: Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271 publication-title: Am. J. Cancer Res. – volume: 6 start-page: 22572 year: 2016 ident: B24 article-title: Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘sponge’ in human cartilage degradation publication-title: Sci. Rep. doi: 10.1038/srep22572 – volume: 8 start-page: 13264 year: 2017 ident: B36 article-title: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway publication-title: Oncotarget doi: 10.18632/oncotarget.14807 – volume: 10 start-page: 329 year: 2015 ident: B6 article-title: Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer publication-title: Oncol. Lett. doi: 10.3892/ol.2015.3179 – volume: 16 start-page: 245 year: 2015 ident: B34 article-title: Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development publication-title: Genome Biol. doi: 10.1186/s13059-015-0801-3 – volume: 442 start-page: 823 year: 2006 ident: B2 article-title: Notch signalling regulates stem cell numbers in vitro and in vivo publication-title: Nature doi: 10.1038/nature04940 – volume: 106 start-page: 700 year: 2015 ident: B17 article-title: MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway publication-title: Cancer Sci. doi: 10.1111/cas.12656 – volume: 66 start-page: 9.e7 year: 2017 ident: B28 article-title: Translation of CircRNAs publication-title: Mol. Cell doi: 10.1016/j.molcel.2017.02.021 – volume: 25 start-page: 1105 year: 2009 ident: B33 article-title: TopHat: discovering splice junctions with RNA-Seq publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp120 – volume: 292 start-page: 141 year: 2010 ident: B37 article-title: Cross-talk between miRNA and Notch signaling pathways in tumor development and progression publication-title: Cancer Lett. doi: 10.1016/j.canlet.2009.11.012 – volume: 38 start-page: 725 year: 2017 ident: B41 article-title: miR-543 functions as a tumor suppressor in glioma in vitro and in vivo publication-title: Oncol. Rep. doi: 10.3892/or.2017.5712 – volume: 7 start-page: e30590 year: 2012 ident: B32 article-title: Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling publication-title: PLoS One doi: 10.1371/journal.pone.0030590 – volume: 165 start-page: 289 year: 2016 ident: B10 article-title: Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations publication-title: Cell doi: 10.1016/j.cell.2016.03.020 – volume: 2014 start-page: 381917 year: 2014 ident: B3 article-title: MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumors publication-title: Biomed Res. Int. doi: 10.1155/2014/381917 – volume: 66 start-page: 1151 year: 2017 ident: B12 article-title: Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression publication-title: Hepatology doi: 10.1002/hep.29270 – volume: 5 start-page: 621 year: 2008 ident: B100 article-title: Mapping and quantifying mammalian transcriptomes by RNA-Seq publication-title: Nat. Methods doi: 10.1038/nmeth.1226 – reference: 20190569 - Cell Cycle. 2010 Mar 15;9(6):1031-6 – reference: 25783790 - Cancer Sci. 2015 Jun;106(6):700-8 – reference: 27373735 - Brief Bioinform. 2017 Sep 1;18(5):780-788 – reference: 28744405 - Am J Cancer Res. 2017 Jul 01;7(7):1566-1576 – reference: 28415618 - Oncotarget. 2017 May 23;8(21):34961-34970 – reference: 20007775 - Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8 – reference: 28921827 - Cancer Sci. 2017 Dec;108(12):2366-2372 – reference: 28859546 - Biosci Biotechnol Biochem. 2017 Oct;81(10):1899-1907 – reference: 29337055 - Biochem Biophys Res Commun. 2018 Mar 25;498(1):254-261 – reference: 22479456 - PLoS One. 2012;7(3):e33844 – reference: 26138677 - Cell Res. 2015 Aug;25(8):981-4 – reference: 24039610 - PLoS Genet. 2013;9(9):e1003777 – reference: 28744130 - Neuropsychiatr Dis Treat. 2017 Jul 11;13:1805-1813 – reference: 26541409 - Genome Biol. 2015 Nov 05;16:245 – reference: 23529798 - J Neurooncol. 2013 Jun;113(2):221-8 – reference: 16799564 - Nature. 2006 Aug 17;442(7104):823-6 – reference: 11964309 - Blood. 2002 May 1;99(9):3398-403 – reference: 19714243 - PLoS One. 2009 Aug 28;4(8):e6816 – reference: 28129650 - Oncotarget. 2017 Feb 21;8(8):13264-13276 – reference: 18516045 - Nat Methods. 2008 Jul;5(7):621-8 – reference: 28639908 - Tumour Biol. 2017 Jun;39(6):1010428317705850 – reference: 25050346 - Biomed Res Int. 2014;2014:381917 – reference: 28771526 - PLoS One. 2017 Aug 3;12(8):e0182305 – reference: 22363450 - PLoS One. 2012;7(2):e30590 – reference: 27613831 - Oncotarget. 2016 Sep 27;7(39):63449-63455 – reference: 26945092 - J Med Genet. 2016 Jun;53(6):359-65 – reference: 10528225 - J Cell Physiol. 1999 Dec;181(3):393-409 – reference: 28344080 - Mol Cell. 2017 Apr 6;66(1):9-21.e7 – reference: 15576902 - Methods Mol Biol. 2005;294:23-9 – reference: 19289445 - Bioinformatics. 2009 May 1;25(9):1105-11 – reference: 20022691 - Cancer Lett. 2010 Jun 28;292(2):141-8 – reference: 26931159 - Sci Rep. 2016 Mar 02;6:22572 – reference: 28977896 - Oncotarget. 2017 Jun 27;8(37):61687-61697 – reference: 12666205 - Dev Dyn. 2003 Apr;226(4):675-89 – reference: 17944672 - Oral Dis. 2007 Nov;13(6):555-63 – reference: 28472320 - Nucleic Acids Res. 2017 Jul 27;45(13):e120 – reference: 28627653 - Oncol Rep. 2017 Aug;38(2):725-734 – reference: 28536644 - Oncol Lett. 2017 May;13(5):3866-3872 – reference: 29086764 - Cell Res. 2017 Dec;27(12):1401-1402 – reference: 29198335 - Crit Rev Oncol Hematol. 2017 Dec;120:22-33 – reference: 26171025 - Oncol Lett. 2015 Jul;10(1):329-336 – reference: 28068630 - Biomed Pharmacother. 2017 Mar;87:405-411 – reference: 27040497 - Cell. 2016 Apr 7;165(2):289-302 – reference: 28924364 - Int J Med Sci. 2017 Aug 8;14(10):937-942 – reference: 28344082 - Mol Cell. 2017 Apr 6;66(1):22-37.e9 – reference: 18803879 - BMC Cancer. 2008 Sep 21;8:266 – reference: 28520103 - Hepatology. 2017 Oct;66(4):1151-1164 – reference: 24393844 - Biochem Biophys Res Commun. 2014 Jan 31;444(1):6-12 |
| SSID | ssj0062653 |
| Score | 2.4699178 |
| Snippet | : The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study investigated the... Objective: The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study... Objective : The present study aimed to explore the association between NFIX circular RNA (circNFIX) and miR-34a-5p in glioma. Furthermore, this study... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 225 |
| SubjectTerms | Apoptosis Cell growth Cell migration Cell viability Cholecystokinin Circular RNA Flow cytometry Gene expression Genomes glioma Glioma cells Lung cancer Medical prognosis MicroRNAs miR-34a-5p miRNA Neuroscience Neurosurgery NFIX circular RNA Notch signaling pathway NOTCH1 Notch1 protein Signal transduction Transplantation Tumors Wound healing |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUqDlUvVUtpGwqVK3HhEK3j2El8BNQtrcQKLUXam-VPGolNECwg_j1jO7varar20mNiR3LG47w3mdEbhA4EdR4cx-bEugYCFFfmgDtBCZMyazQnOsoXn02q00v2Y8Zna62-Qk1YkgdOhhtZQ61QptRV7RlXXjNXaEAloX3jSmLC1xcwbxlMpW8wsHRepqQkhGBi5Lt5H_IMRSycDG2x10AoavX_iWD-Xie5BjzjN-j1wBjxUVrpW_TCddvo5dmQE3-H9GT8fYZP2ttYUYqnkyN8Hmvs3B3-dt32cxWur1K9a4f1E56m_vMAWnjeTvOSqZzf4IdW4UkPm4gv2qtAz2H4HPjho3raQZfjrz9PTvOhc0JumCCLnDlhm8pXzHKluasdRDUFgLnQhedFU3FBnPOuMgDgltaGWCAOnitLC28sNeV7tNX1nfuIsAHCQrSgRAnBvIPYW1OhFNO18AT2JUOjpSmlGWTFQ3eLawnhRTC-jMaXwfgyGj9Dh6snbpKkxl_mHofdWc0LYtjxBriIHFxE_stFMrS33Fs5nNA7CaGX4FEdJ0NfVsNwtkLCRHWuv4c5wE_rggKjztCH5AqrlZRBc72pRIbqDSfZWOrmSNf-ivrdIRMNkePu_3i3T-hVsFb421w0e2hrcXvv9oEmLfTneCKeAfyiErQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxNBEB80BfFF_PZqlRV88eHIfeze3T5JWxqr0BCihbwd-xkPmruYpJX-987ubWIj0sdk92CZmZ35zc7wG4CPPDMWDUfHiTYVJigmjzHuOCbMjGolWSI9ffHFuDi_pN9mbBYe3NahrXLrE72j1p1yb-RDhMqceTaTz8tfsZsa5aqrYYTGQzhAF1xVAzg4ORtPpltfjGid5X1xElMxPrTtonP1htQ3ULrx2HeCkefs_x_Q_Ldf8k4AGj2FJwE5kuNe1c_ggWmfw6OLUBt_AXI8-jojp83Kd5aS6fiYTHyvnVmTL1dNtxDu97zve22JvCXTfg49Bi-yaKZxTkXMluSmEWTcoTLJ92buYDouTxAn_ha3L-FydPbj9DwOExRiRXmyianhuipsQTUTkpnSYHaTYlDnMrUsrQrGE2OsKRQGcp2VKtEIICwTOkut0pnKX8Gg7VrzBohC4JJIniWCc2oN5uAy40JQWXKbCJVHMNyKslaBXtxNubiqMc1wwq-98Gsn_NoLP4JPuy-WPbXGPXtPnHZ2-xwptv-jW83rcMdqrTLN8SiyKC1lwkpqUokAhktbmTxRERxtdVuHm7qu_9pVBB92y3jHXOFEtKa7xj2IU8s0Q2QdweveFHYnyR33elXwCMo9I9k76v5K2_z0PN6uIo0Z5OH9x3oLj50c3HtyWh3BYLO6Nu8QCG3k-2DtfwCofwn8 priority: 102 providerName: ProQuest |
| Title | NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30072869 https://www.proquest.com/docview/2309500494 https://www.proquest.com/docview/2083712020 https://pubmed.ncbi.nlm.nih.gov/PMC6058096 https://doaj.org/article/dc2d9ac3b67f45afb4e1b8129bf8e30c |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fi9NAEF70DsQX8bfRs6zgiw_xks1ukn0QuTuudwoNpVroW9ifvUCbnL2e2v_e2U0arRTBl0K6m7DMzjLfl5l8g9BbTowFx9FhpE0OBMUkIcQdp4RJqFaSRdLLF4-K9HJKP8_Y7Pfn0Z0Bb_ZSO9dParpavP_5bfMRDvwHxzgh3h7betm4LELsyyIJu4sOIS5lrp_BiPY5BUDuXpMyTlOgXwCM2qTl3ifsBCmv5b8PgP5dR_lHYBo-RA86RIlPWhd4hO6Y-jG6N-py5k-QLIafZvisWvmKUzwpTvDY1-CZG3yxqJqlcNfzth62xnKDJ21_eghqeFlNwoSKkF3j75XARQObjL9UcwffYXgM-PGH2DxF0-H517PLsOusECrKo3VIDdd5alOqmZDMZAZYTwzBnsvYsjhPGY-MsSZVEOA1yVSkAVhYJjSJrdJEJc_QQd3U5gXCCgBNJDmJBOfUGuDmknAhqMy4jYRKAnS8NWWpOtlx1_1iUQL9cMYvvfFLZ_zSGz9A7_o7rlvJjX_MPXW7089zYtn-j2Y1L7uzV2pFNIelyDSzlAkrqYklABsubW6SSAXoaLu35dYBS6BmnHn1nAC96Yfh7LmEiqhNcwtzAL9mMQHEHaDnrSv0K0mcJnue8gBlO06ys9Tdkbq68vreLlMNzPLlf9jhFbrvLtxL5zg_Qgfr1a15DWhpLQfo8PS8GE8G_m0D_F7M4oE_GL8AnCIVug |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDeGAosEBw5W7PVzDwi1pSGhjRWFVsrN3Wew1NghSanyp_iNzK7t0CDUW4_2rq3V7OzMN57xNwi9p0RpUBzpelKlEKCowAW_Y5gwSSgFjzxu6YuHWdw_C79NoskO-t3-C2PKKlubaA21rIT5Rt4FqEwjy2byef7TNV2jTHa1baFRq8WxWl9ByLb8NPgC-_uBkN7R6WHfbboKuCKk3soNFZVprONQRoxHKlGA-H1wdJT7OvLTOKKeUlrFApybJInwJDhVHTFJfC0kEQG89w7aDYPYIx20e3CUjcat7YfoIArqZCiEfrSry1ll8hu-Ldg07bivOT_bI-B_wPbf-sxrDq_3ED1okCrer1XrEdpR5WN0d9jk4p8gnvUGE3xYLGwlKx5n-3hka_vUEn-9KKoZM9fTus62xHyNx3Xfe3CWeFaM3SBkbjTHvwqGswqUB38vpiYsgOER4NIrtn6Kzm5Fts9Qp6xK9QJhAUDJ45R4jNJQK4j5OaGMhTyh2mMicFC3FWUuGjpz01XjIoewxgg_t8LPjfBzK3wHfdw8Ma-pPG6Ye2B2ZzPPkHDbG9VimjdnOpeCSApL4XGiw4hpHiqfA2CiXKcq8ISD9tq9zRvLsMz_6rGD3m2G4UybRA0rVXUJcwAXJz4BJO-g57UqbFYSGK73NKYOSraUZGup2yNl8cPyhpsMOESsL29e1lt0r386PMlPBtnxK3TfyMR8y_bTPdRZLS7VawBhK_6m0XyMzm_7sP0BJ1tHKQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVKq4IN4YCiwSHDhYsdde23tAqK_QUGpFgUq9mX0GS40dkpQqf41fx-zaDg1CvfVo79pazc7sfJ9nPIPQW0a0AcVRfqB0BgRFRz74HVsJk8RKChoIV774NE-Oz-LP5_R8C_3u_oWxaZXdmegOalVL-428D1CZUVfNpG_atIjR4eDj7KdvO0jZSGvXTqNRkRO9ugL6tvgwPIS9fkfI4OjbwbHfdhjwZcyCpR9rprLEJLGiXFCdakD_ITg9JkJDwyyhLNDa6ESCo1MklYECB2soVyQ0UhEZwXvvoO3UsqIe2t4_ykfjzg8AU6BRExgFGsj6pprWNtYRuuRN25r7miN0_QL-B3L_zdW85vwG99G9FrXivUbNHqAtXT1EO6dtXP4REvlgeI4PyrnLasXjfA-PXJ6fXuBPF2U95fZ60uTcVlis8FhPXOOwaoKn5diPYu7TGf5VcpzXoEj4azmxFAGGR4BRr_jqMTq7Fdk-Qb2qrvQzhCWApkAwEnDGYqOB_wvCOI9FykzAZeShfifKQralzW2HjYsCKI4VfuGEX1jhF074Hnq_fmLWlPW4Ye6-3Z31PFuQ292o55Oite9CSaIYLEUkqYkpNyLWoQDwxITJdBRID-12e1u0p8Si-KvTHnqzHgb7tkEbXun6EuYARk5DAqjeQ08bVVivJLJ137OEeSjdUJKNpW6OVOUPV0PcRsOBvT6_eVmv0Q4YWfFlmJ-8QHetSOxn7TDbRb3l_FK_BDy2FK9axcfo-23b2h8vRUte |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NFIX+Circular+RNA+Promotes+Glioma+Progression+by+Regulating+miR-34a-5p+via+Notch+Signaling+Pathway&rft.jtitle=Frontiers+in+molecular+neuroscience&rft.au=Xu%2C+Haiyang&rft.au=Zhang%2C+Yu&rft.au=Qi%2C+Ling&rft.au=Ding%2C+Lijuan&rft.date=2018-07-18&rft.issn=1662-5099&rft.eissn=1662-5099&rft.volume=11&rft_id=info:doi/10.3389%2Ffnmol.2018.00225&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fnmol_2018_00225 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-5099&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-5099&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-5099&client=summon |